Financhill
Back

Apellis Pharmaceuticals Vs. Byrna Technologies Industry Stock Comparison

Sell
31

APLS
Apellis Pharmaceuticals

Last Price:
$17.64
Seasonality Move:
-9.52%
Buy
51

BYRN
Byrna Technologies

Last Price:
$31.64
Seasonality Move:
-15.08%
Sell
31
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.62. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Byrna Technologies (BYRN) is a Buy

Is Byrna Technologies a Buy, Sell or Hold?

  • The current Byrna Technologies [BYRN] share price is $31.67. The Score for BYRN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • BYRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

BYRN Stock Price Chart

What is Byrna Technologies's stock price today?

  • The Byrna Technologies share price today is $31.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BYRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 42.42 Sell
Chaikin Money Flow: 648223 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.32 - 19.04) Sell
Bollinger Bands (100): (17.64 - 26.36) Sell

BYRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.93 Buy
Relative Strength Index (14 RSI): 64.06 Buy
Chaikin Money Flow: 333456 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.11 - 30.49) Buy
Bollinger Bands (100): (19.38 - 29.24) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.31 Sell
20-day SMA: 18.29 Sell
50-day SMA: 18.23 Sell
200-day SMA: 26.72 Sell
8-day EMA: 18.11 Sell
20-day EMA: 18.29 Sell
50-day EMA: 19.17 Sell
200-day EMA: 26.88 Sell

BYRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.84 Buy
20-day SMA: 28.6 Buy
50-day SMA: 24.92 Buy
200-day SMA: 22.2 Buy
8-day EMA: 30.61 Buy
20-day EMA: 28.85 Buy
50-day EMA: 26.12 Buy
200-day EMA: 21.82 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Byrna Technologies Earnings Growth & BYRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.06 per share, an increase this year of $0.13 per share, and an increase next year of $0.14 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Byrna Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):